 |
|
|
| |
SHORT AND LONG-TERM BODY WEIGHT GAIN FOLLOWING
SWITCH TO INTEGRASE INHIBITORS DIFFERS BY SEX
|
| |
| |
CROI 2024 March 3-6 Denver
Cecile D. Lahiri1, C. Christina Mehta1, Qian Yang1, Joffi Musonge-Effoe1, Julie B. Dumond2, Maria L. Alcaide3, Jordan E. Lake4, Leah H. Rubin5, Audrey L. French6,
Jennifer Cocohoba7, Seble Kassaye8, Anjali Sharma9, Anandi N. Sheth1, Igho Ofotokun1, Jessica A. Alvarez10
1Emory University School of Medicine, Atlanta, GA, USA; 2University of North Carolina School of Pharmacy, Chapel Hill, NC, USA; 3University of Miami, Miller School of Medicine, Miami, FL, USA; 4UTHealth, Houston, TX, USA; 5Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; 6Stroger Hospital of Cook County Health, Chicago, IL, USA;
7University of California San Francisco School of Pharmacy, San Francisco, CA, USA; 8Georgetown University Medical Center, Washington, DC, USA; 9Albert Einstein College of Medicine, Bronx, NY, USA; 10 Emory University School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism, and Lipids, Atlanta, GA, USA
|
| |
|
|
|
|
|
